Genesis Research Group today announced that its EVID AI evidence synthesis platform will be available free of charge through ...

Sanofi’s Cenrifki (tolebrutinib) has been approved by the European Commission to treat secondary progressive multiple ...

AbbVie has announced it will acquire Apogee and its diverse pipeline of multiple clinical-stage candidates in development ...

Medscape Education, the leading global provider of continuing medical education (CME), has announced its agenda for the ...

Regeneron Pharmaceuticals has announced that both the US FDA and the European Medicines Agency (EMA) have accepted the ...

Sanofi has appointed Paulo Fontoura as Executive Vice President, Global Head of Research & Development Pharma, effective 1 ...

Lundbeck has appointed Tarek Samad as Executive Vice President and Head of Research & Development (R&D). Samad will join the Executive Leadership Team (ELT), effective 1 September 2026. Samad ...

The tablets will be available as a once-daily treatment, an alternative to weekly injections for adults with obesity, or ...

Pfizer has appointed Cecile Guegan, currently Senior Vice President, Finance, Global Biopharmaceutical Business, as Interim ...

Biogen has agreed to acquire RayThera for up to $1bn, consisting of an upfront payment and payments contingent on the achievement of future clinical and regulatory milestones. RayThera is a private ...

Key insights from ASCO® 2026, including oncology trends, scientific highlights, and strategies for smarter congress ...

Broken String Biosciences has appointed Bruce Eaton as Chairman of the Board, with immediate effect. The appointment aligns ...